Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer, Secondary cancers
Closed
Phase 3
This trial is looking at adding giredestrant to Phesgo to improve treatment for breast cancer.
It is for people whose cancer has grown into surrounding tissues or has spread to other parts of the body. Also, the cancer:
has tested positive for
has
Recruitment start: 16 September 2022
Recruitment end: 16 July 2025
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Catherine Harper-Wynne
Roche
Last reviewed: 16 July 2025
CRUK internal database number: 18563
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
